Tag: Procurement

  • President Buhari Approves Fund For Arms Procurement |Politics Today|

    https://www.youtube.com/playlist?list=PL3ZQ5CpNulQk7-xjal0utY_5dIAs0bwmk

    President Buhari Approves Fund For Arms Procurement |Politics Today|

    Views: 0

  • WHO and European Investment Bank strengthen efforts to combat COVID-19 and build resilient health systems to face future pandemics

    • WHO and the European Investment Bank enhance cooperation to support countries in addressing the health impact of COVID-19
    • The first phase will address urgent needs and strengthen primary health care in ten African countries
    • Enhanced WHO-EIB partnership will scale up financing to assure the chain of essential supplies, including personal protective equipment, diagnostics and clinical management
    • New initiative will accelerate investment in health preparedness and primary health care with a focus on health work force, infrastructure, and water, sanitation and hygiene
    • The initiative involves measures to address the growing threat of antimicrobial resistance

    The World Health Organization and the European Investment Bank will boost cooperation to strengthen public health, supply of essential equipment, training and hygiene investment in countries most vulnerable to the COVID-19 pandemic.

    The new partnership between the United Nations health agency and the world’s largest international public bank, announced at WHO headquarters in Geneva earlier today, will help increase resilience to reduce the health and social impact of future health emergencies. 

    “Combining the public health experience of the World Health Organization and the financial expertise of the European Investment Bank will contribute to a more effective response to COVID-19 and other pressing health challenges,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. 

    “WHO looks forward to strengthening cooperation with the EIB to improve access to essential supplies including medical equipment and training, and deliver better water, sanitation and hygiene where most needed. New initiatives to improve primary health care in Africa and support the EU Malaria Fund hint at the potential impact of our new partnership,” Dr Tedros concluded.

    “The world is facing unprecedented health, social and economic shocks from COVID-19. The European Investment Bank is pleased to join forces with the World Health Organization as a key part of Team Europe’s efforts to address the global impact of the COVID-19 pandemic. The EU Bank’s new partnership with the WHO will help communities most at risk by scaling up local medical and public health efforts and better protect people around the world from future pandemics. This new cooperation will enable us to combat malaria, address anti-microbial resistance and enhance public health in Africa more effectively,” said Werner Hoyer, President of the European Investment Bank.

    Improving local public health efforts to tackle coronavirus

    The WHO and the EIB will increase cooperation to help governments in low- and middle-income countries to finance and secure access to essential medical supplies and protective equipment through central procurement.

    Building resilient health systems in vulnerable countries across Africa

    The WHO and the EIB will reinforce cooperation to support immediate COVID-19 needs and jointly develop targeted financing to enhance health investment and build resilient health systems and primary health care to address public health emergencies as well as accelerate progress towards Universal Health Coverage.

    The partnership will benefit from the EIB’s planned 1.4 billion EUR response to address the health, social and economic impact of COVID-19 in Africa.

    This will address immediate needs in the health sector and provide both technical assistance and support for medium-term investment in specialist health infrastructure.

    The collaboration envisages rapid identification and fast-track approval of financing for health care, medical equipment and supplies. 

    The first phase of the collaboration will see public health investment in ten African countries. 

    Long-term collaboration to overcome market failures in global health

    The agreement signed today establishes a close collaboration to overcome market failure and stimulate investments in global health, accelerating progress towards Universal Health Coverage. Increased cooperation between the WHO and the EIB will strengthen the resilience of national public health systems and enhance preparedness of vulnerable countries against future pandemics, thanks to investments in primary care infrastructure, health workers and improved water, sanitation and hygiene. 

    Future cooperation will strengthen the EIB’s 5.2 billion EUR global response to COVID-19 outside the European Union.

    Scaling up investment to tackle antimicrobial resistance

    The two organisations will also cooperate in an initiative to address investment barriers hindering development of new antimicrobial treatment and related diagnostics. Antimicrobial resistance is amongst the most significant global health threats.

    The WHO and the EIB are working on a new financing initiative to support development of novel antimicrobials and address the estimated 1 billion EUR needed to provide medium-term solutions to antimicrobial resistance. Other crucial partners have been invited to join this discussion. 

    Improving the effectiveness of malaria treatment

    Under the new agreement the EIB and WHO will support development of the EU Malaria Fund, a new 250 million EUR public-private initiative intended to address market failures holding back more effective malaria treatment. 

    Strengthening EIB support for healthcare, life science and COVID-19 investment

    In recent years the European Investment Bank has provided more than 2 billion EUR annually for health care and life science investment.

    In the context of the COVID-19 pandemic, the EIB is currently assessing over 20 projects in the field of vaccine development, diagnostic and treatment, leading to potential investments in the 700 million EUR range. The EIB will also take part in the EU’s rolling pledging effort for the coronavirus global response that is taking place on May 4th.

    Background information

    The European Investment Bank (EIB) is the long-term lending institution of the European Union owned by its Member States. It makes long-term finance available for sound investment in order to contribute towards EU policy goals.

    The World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States, across six regions and from more than 150 offices, to promote health, keep the world safe and serve the vulnerable. Our goal for 2019-2023 is to ensure that a billion more people have universal health coverage, to protect a billion more people from health emergencies, and provide a further billion people with better health and wellbeing. For updates on COVID-19 and public health advice to protect yourself from coronavirus, visit www.who.int and follow WHO on Twitter, Facebook, Instagram, LinkedIn, TikTok, Pinterest, Snapchat, YouTube

    WHO’s information site on the COVID-19 pandemic

    Read More
    https://www.who.int/news-room/detail/01-05-2020-who-and-european-investment-bank-strengthen-efforts-to-combat-covid-19-and-build-resilient-health-systems-to-face-future-pandemics

    Views: 0

  • WHO lists two COVID-19 tests for emergency use

    WHO has listed the first two diagnostic tests for emergency use during the Covid-19 pandemic. The move should help increase access to quality-assured, accurate tests for the disease.  It also means that the tests can now be supplied by the United
    Nations and other procurement agencies supporting the COVID-19 response.

    Both in vitro diagnostics, the tests are genesig Real-Time PCR Coronavirus (COVID-19) and cobas SARS-CoV-2 Qualitative assay for use on the cobas® 6800/8800 Systems. 

    “The emergency use listing of these products will enable countries to increase testing with quality assured diagnostics,” says Dr Mariângela Simão, WHO Assistant-Director General for Medicines and Health Products. “Facilitating
    access to accurate tests is essential for countries to address the pandemic with the best tools possible.” 

    The Emergency Use Listing procedure (EUL) was established to expedite the availability of diagnostics needed in public health emergency situations. It is intended to help procurement agencies
    and countries navigate the large presence of different devices on the market and, by assessing them, provides assurance of the products’ quality and performance.

    The genesig Real-Time PCR Coronavirus (COVID-19) (Primerdesign, United Kingdom) is an open system more suitable for laboratories with moderate sample testing capacity, while the cobas® SARS-CoV-2 for use on the cobas® 6800/8800 Systems (Roche, United States of America) is a closed system assay for larger laboratories.

     

    EUL listed products:

    https://www.who.int/diagnostics_laboratory/200407_eul_sars_cov2_product_list.pdf?ua=1

    Roche test:

    https://www.who.int/diagnostics_laboratory/eul_0504-046-00_cobas_sars_cov2_qualitative_assay_ifu.pdf?ua=1

    Primerdesign test:

    https://www.who.int/diagnostics_laboratory/eul_0489_185_00_path_covid19_ce_ivd_ifu_issue_2.0.pdf?ua=1

    Read More
    https://www.who.int/news-room/detail/07-04-2020-who-lists-two-covid-19-tests-for-emergency-use

    Views: 0

  • Forum Tells Buhari, Governors To Begin Payment Of Stipend To Low-income Earners Over Coronavirus Lockdown

    Forum Tells Buhari, Governors To Begin Payment Of Stipend To Low-income Earners Over Coronavirus Lockdown

    Forum Tells Buhari, Governors To Begin Payment Of Stipend To Low-income Earners Over Coronavirus Lockdown 1

    Forum Tells Buhari, Governors To Begin Payment Of Stipend To Low-income Earners Over Coronavirus Lockdown 2


    The Third Force Forum has urged President Muhammadu Buhari and the Nigerian Governors Forum to start the fee of between N20,000 to N40,000 to low-income earners and self-employed Nigerians as “COVID-19 Intervention Fund”.

    The discussion board stated the fee must be made to individuals, who earn beneath N50,000 month-to-month.

    The group posited that pressing actions should be taken to mitigate the impact of the outbreak of Coronavirus on the individuals.

    The discussion board can also be asking the presidency to transform 50 per cent of the safety vote and catering finances of Aso Rock to a “COVID-19 Special Fund”.

    The group stated, “Commence a program that permits companies which can be unable to remit VAT between the 20th of March 2020 and the 30th of June 2020 to take action by the 31st of March 2021, to allow a secure enterprise local weather and adaptation to the calls for of the pandemic.

    “Establish a particular COVID-19 Fund Raising Committee charged with the only process of collating funds pledged from the organised personal sector, well-meaning people, worldwide neighborhood and different NGO’s. The funds will likely be used to sponsor different palliative measures just like the procurement of meals stuff, face masks, and sanitisers to each native authorities in Nigeria, relying on want.

    “A moratorium on electricity tariffs for at least two months or more and facilitation of and an understanding with the telecommunications companies to commit N2000 to N5000 in Recharge and data per month over the next two months to all mobile subscribers in Nigeria as well as an emergency legislation or Executive Order allowing a three-month moratorium on landlord evictions as a result of the stay-at-home order by the government in affected cities.”

    The discussion board referred to as on the National Assembly to briefly droop the large compensation bundle loved by members comprising Senate House of Representatives by 50 per cent for the rest of 2020 or the period of the nationwide shutdown.

    It warned that failure to contemplate the above could set a stage for an eventual class-warfare in Nigeria.

    PUBLIC HEALTH

    News

    AddThis

    : 

    Original Author

    : 

    SaharaReporters, New York

    Disable ads

    : 
    Forum Tells Buhari, Governors To Begin Payment Of Stipend To Low-income Earners Over Coronavirus Lockdown
    Read More
    http://saharareporters.com/2020/04/03/forum-tells-buhari-governors-begin-payment-stipend-low-income-earners-over-coronavirus

    Views: 0

  • Ensure Accountability For Donated Funds, Civil Society Group Tells Nigerian Government

    Ensure Accountability For Donated Funds, Civil Society Group Tells Nigerian Government

    Ensure Accountability For Donated Funds, Civil Society Group Tells Nigerian Government 3

    Ensure Accountability For Donated Funds, Civil Society Group Tells Nigerian Government 4


     

    A coalition of civil society organisations has urged the Nigerian Government to make sure transparency and accountability within the administration of over N30bn donated by teams, establishments and well-meaning people to assist cease the unfold of Coronavirus.

    In a press release on Thursday by the Centre for Democracy and Development, Women Advocacy Research and Documentation Centre, Journalists for Democratic Rights, Civil Society Network Against Corruption, HURIDAC, Green Peoples Environmental Network, Nigerian Human Rights Community, COPEAIDS Foundation, a health-concern rights group, Civil Society Coalition for Mandate Protection, HELP Center for Development, stated nobody ought to be inspired to revenue from human distress.

    The assertion reads, “We respect all contributors and donors within the emergency funds and supplies in response to the Coronavirus pandemic.

    “The finest that may occur is accountability. No one ought to be inspired to revenue from the present human distress.

    “We urge all government MDAs and special task force to uphold procurement and operational standards and policies in awards and payments of services and distribution of materials.”

    The coalition referred to as for strict monitoring and analysis of the disbursed funds by the Economic and Financial Crimes Commission to make sure that it’s used for public good.

     

    PUBLIC HEALTH

    News

    AddThis

    : 

    Original Author

    : 

    SaharaReporters, New York

    Disable commercials

    : 
    Ensure Accountability For Donated Funds, Civil Society Group Tells Nigerian Government
    Read More
    http://saharareporters.com/2020/04/02/ensure-accountability-donated-funds-civil-society-group-tells-nigerian-government

    Views: 0

  • Medical Product Alert N°3/2020

    This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat or cure COVID-19. 

    The Coronavirus disease (COVID-19) pandemic (caused by the virus SARS-CoV-2) has increased demand for medicines, vaccines, diagnostics and reagents, all related to COVID-19, creating an opportunity for ill-intended persons to distribute falsified medical products 

    Due diligence is required from all actors in the procurement, use and administration of medical products, in particular those affected by the current crisis of, or related to, COVID-19. 

    1. FALSIFIED IN VITRO DIAGNOSTICS AND LABORATORY REAGENTS 

    WHO has received multiple reports regarding falsified in vitro diagnostics (IVDs) and laboratory reagents for the detection of SARS-CoV-2. Please refer to WHO’s Emergency Use Listing for a list of diagnostics approved for clinical use by WHO. To date, eight countries (Australia, Brazil, Canada, PR China, Russian Federation, Singapore, Republic of Korea, United States of America) have listed IVDs for COVID-19 diagnosis based on expedited regulatory assessments. Please note that, in the European Union, regulatory compliance for SARS-CoV-2 diagnostics are self-declared by the manufacturer.  

    To assist Member States and stakeholders, WHO has published the links to these emergency lists, together with contact details. These links provide information on IVDs authorized for use in the jurisdictions of the International Medical Device Regulators Forum, as well as policies and guidance. WHO will provide updated versions as new information becomes available.

    End-users are encouraged to check the labelling against the information posted by regulatory authorities upon listing to ensure they are in possession of the genuine product. This information might include product name, product code, expiry date, instructions for use and manufacturer details. 

    Unregulated websites supplying medicines and/or vaccines, particularly those concealing their physical address or landline telephone number, are frequently the source of unlicensed, substandard and falsified medical products. WHO has been made aware of various unregistered websites claiming that products on sale can treat or prevent COVID-19. Such products are likely to be falsified medicines. In addition, some websites may appear to provide easy access to legitimate medicines that are otherwise not readily available. End-buyers and consumers should be especially wary of such online scams and exert due diligence when purchasing any medical product, whether online or not.

     2. FALSIFIED MEDICINES AND VACCINES

    At this stage, WHO does not recommend any medicines to treat or cure COVID-19. However, the SOLIDARITY trial, led by WHO, is reviewing potential treatments for COVID-19. 

    WHO requests increased vigilance from national health authorities, healthcare professionals, members of the public and supply chain stakeholders worldwide to prevent the distribution of these falsified medical products. Increased vigilance should focus on hospitals, clinics, health centres, clinical laboratories, wholesalers, distributors, pharmacies and any other suppliers of medical products. All medical products must be obtained from authentic and reliable sources. Their authenticity and condition of the product should be carefully checked. Consumers are advised to seek advice from a healthcare professional in case of doubt. 

    National health authorities are requested to immediately notify WHO if these falsified products are discovered in their country. If you have any information concerning the manufacture, distribution, or supply of these products, please contact rapidalert@who.int

    WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products
    For further information, please visit our website: https://www.who.int/medicines/regulation/ssffc/en/ 

    Read More
    https://www.who.int/news-room/detail/31-03-2020-medical-product-alert-n-3-2020

    Views: 0

  • Nigerian Army Redeploys Senior Officers In Major Shake-up

    Nigerian Army Redeploys Senior Officers In Major Shake-up

    Nigerian Army Redeploys Senior Officers In Major Shake-up 5

    Nigerian Army Redeploys Senior Officers In Major Shake-up 6


     

    As earlier reported by SaharaReporters, the Nigerian Army has announced the redeployment of senior officers, claiming that the move was in a bid to add freshness into the war against terrorism in the country.

    The posting, which was approved by the Chief of Army Staff, Lt Gen Tukur Yusuf Buratai, led to the removal of Maj. Gen. Olusegun Adeniyi as Theatre Command Operation LAFIYA DOLE, the group fighting Boko Haram terrorists in the North-East region of the country.

    Adeniyi, who spoke out against the lack of weapons and accurate intelligence to fight terrorists in the region in a video that went viral a few days ago, was moved to the Nigerian Army Resource Centre as Senior Research Fellow after his outburst embarrassed the military authorities. 

    See Also

    Nigerian Army Redeploys Senior Officers In Major Shake-up 7

    Breaking News

    BREAKING: Nigerian Army Removes General In Viral Video Asking For Weapons To Fight Boko Haram


    In a statement on Tuesday, Acting Director Army Public Relations, Col. Sagir Musa, said, “The major highlight of the posting includes the posting and appointment of Maj Gen ACC Agundu from Special Task Force, Operation SAFE HAVEN, Jos, to Nigerian Army Resource Centre (NARC), Abuja, as Senior Research Fellow, Major General HI Bature from Defence Headquarters (DHQ), Defence Liaison Office, National Assembly Abuja, to Army Headquarters, Department of Civil Military Affairs and appointed Chief of Civil-Military Affairs, Maj Gen UM Mohammed from Nigerian Army Property Limited (NAPL) to the Office of the Chief of Army Staff and appointed Special Adviser Nigerian Army University Biu/Deputy Chairman Board of Trustees NAPL, while the erstwhile Special Adviser Nigerian Army University Biu Maj Gen CC Okonkwo now redeployed to STF Operation SAFE HAVEN Jos  and appointed Commander, Maj Gen F Yahaya from Headquarters 1 Division Kaduna to Headquarters.

    “Theatre Command Operation LAFIYA DOLE (OPLD) Maiduguri and appointed Commander, while Maj Gen OG Adeniyi is redeployed from Headquarters Theatre Command OPLD Maiduguri to NARC as Senior Research Fellow, Maj Gen S Idris from Sector 2 OPLD Damaturu- Yobe State redeployed to DHQ Abuja and appointed Director Liaison. 

    “Others affected include – Maj General AA Adesope from Office of the Chief of Army Staff Directorate of Audit and Financial Management to NAPL and appointed Group Managing Director, Maj Gen MG Ali from Headquarters Theatre Command OPLD Maiduguri to Headquarters 4 Special Forces Command Doma, Nasarawa State as Commander while the erstwhile Chief of Civil-Military Affairs AHQ Abuja Maj Gen US Mohammed has been redeployed to 1 Division Kaduna and appointed General Officer Commanding. 

    “Similarly, Brig Gen HI Daniel from the Defunct  Army Special Forces Command Maiduguri to Headquarters Training and Doctrine Command Minna and appointed Director Army Training Support, Brig Gen BE Onyeuko is to remain in DHQ Abuja as Acting Director Defence Media Operation, Brig Gen NM Jega from Training and Doctrine Command Minna to Infantry Corps Centre Jaji and appointed Chief of Staff, Brig Gen LA Araba from Nigerian Army Welfare Limited by Guaranty Abuja now redeployed to Sector 2 OPLD Damaturu, Yobe State as Ag Commander, Brig Gen VO Ita from DHQ, Abuja to Headquarters 402 Special Forces Brigade Azare and appointed Commander while Brig Gen JAL Jimoh from Sector 3 Artillery Brigade OPLD Monguno to Headquarters 31 Brigade Minna and appointed Commander and Brig Gen GTO Ajetunmobi has been redeployed from 31 Brigade Minna to Nigeria Army Welfare Limited by Guaranty, Abuja as Executive Director Operation. 

    See Also

    Nigerian Army Redeploys Senior Officers In Major Shake-up 8

    Boko Haram

    How Boko Haram Terrorists Dealt Us Heavy Blow –Nigerian Army Commander


    “Others are – Brig Gen LG Lepdung from Headquarters Infantry Corps Centre Jaji to DHQ Abuja and appointed Deputy Director Procurement (Logistics), Brig Gen MO Ihanuwaze to remain in Office of the Chief of Army Staff Directorate of Audit and Financial Management as Acting Director, Brig Gen EC Obi – Osang from the defunct Headquarters 707 Special Forces’ Brigade Makurdi to Headquarters 401 Special Forces’ Brigade Makurdi as Commander while Brig Gen GM Mutkut is redeployed from the Defunct Nigerian Army Amphibious Command OPLD Baga to Headquarters 403 Amphibious Brigade Baga and appointed Commander and Brig Gen JR Lar from Nigerian Army School of Artillery Kachia to Sector 3 Artillery Brigade OPLD Monguno as Commander.

    “Also, Colonel DJ Abdullahi from the defunct Headquarters Nigerian Army Special Forces’ Command Maiduguri to Headquarters 4 Special Forces’ Command Doma Nasarawa State and appointed Acting Chief of Staff, Colonel EC Emere from Nigerian Army Archives to Nigerian Military School Zaria as Deputy Commandant and Col MO Agi is to remain in Headquarters Nigerian Army Armour Corps Bauchi as Acting Chief of Staff among others.

    “All the postings and appointments take effect from the 1st of April 2020. 

    “While wishing all the officers well in their respective appointments, the Chief of Army Staff enjoins them to take their new responsibilities/appointments seriously and discharge all duties professionally with utmost loyalty to the Nation and the Service.” 

    Military

    News

    AddThis

    : 

    Original Author

    : 

    SaharaReporters, New York

    Disable advertisements

    : 
    Nigerian Army Redeploys Senior Officers In Major Shake-up
    Read More
    http://saharareporters.com/2020/03/31/nigerian-army-redeploys-senior-officers-major-shake

    Views: 0

  • Autonomous on-demand buses underway in the streets of Europe

    Autonomous on-demand buses underway in the streets of Europe

    Would you like to take a ride on a driverless bus? This will be possible in five European cities between April and October 2020, where autonomous buses will be tested in real-life traffic conditions. Three international consortia have been awarded with contracts for the final phase of the pre-commercial procurement under the EU-funded FABULOS project. These consortia will pilot autonomous buses as part of the existing public transport systems. The initial tests will run in Gjesdal (Norway), Helsinki (Finland) and Tallinn (Estonia) in the spring and autumn. Pilots will also be launched in Lamia (Greece) and Helmond (the Netherlands).

    Read More

    Views: 0

  • Department Administrator Interference in the Doctor-Patient Relationship

    [ad_1]

    I contacted a resident doctor in Internal Medicine at a teaching hospital and asked if he would be interested in becoming my primary care physician (PCP). My note briefly described my background in health outcomes research and two of my prescription drugs. He wrote back that he would be honored to be my PCP, and came across as professional, humble, and sincere. A new doctor-patient relationship was formed, and I contacted my existing doctor’s office to arrange for my medical records to be transferred, which immediately informed that office that I must be dissatisfied and going to a new doctor. I also shared with the resident doctor confidential information from my medical records and a copy of one of my professional presentations at a health care conference.

    A department administrator then contacted me to say the resident doctors are not available every day of the week for clinic and are not even here when they do their ICU rotation. Also, the Internal Medicine department protocol would not allow the resident doctor to write me a drug prescription for off label use. Finally, she was concerned that in the past I have ordered and correctly interpreted my own blood tests. The administrator’s attitude reflects one of the chief complaints Americans have with the health care system: the system is coming at them and requiring them to get health services in some predefined structure to which the facility is accustomed but which eliminate any potential for individualized treatment according to individual patients’ needs.

    Apparently the administrator did not spend enough “careful consideration” to get her facts straight. I do not need to see my PCP daily or even monthly. My track record shows I saw my existing doctor once in a calendar year, and the prior doctor before him I saw once in a 15-month period. So the administrator based her decision on her own ignorance of the facts.

    She also misstated facts concerning off-label prescriptions for drugs by resident doctors. One of the drugs we are talking about is Clomiphene. Both a resident doctor and an attending faculty physician at the teaching hospital advised me that they would be willing to write me (off-label) prescriptions for this drug, and the attending physician did indeed phone in a prescription for one of the drugs at my request. Similarly, the Dept. of Obstetrics and Gynecology (OB-GYN) advised me that their doctors, both resident and attending, have prescribed Clomiphene to patients. Therefore, residents in Family Medicine and OB-GYN (both primary care departments) can write prescriptions for Clomiphene, but “protocol” prevents residents in Internal Medicine (also primary care) from writing off-label prescriptions. What kind of a cockamamie rule is that? What, the residents in Internal Medicine are too dumb or too naive to understand off-label benefits of medicines?

    Finally, I had planned for my resident PCP to order and interpret blood tests each time I visited him. The administrator could have learned that fact if she had bothered to call or write me before jumping to conclusions and interfering in my doctor-patient relationship. I strongly reject the Director’s paternalistic view of medicine in which she feels she has to protect resident doctors from patients who order or interpret their own blood tests. These resident doctors are young professionals who have completed their medical degrees; they don’t need paternalistic oversight from a department administrator telling them who they can and cannot invite to be patients.

    Apparently, an overwhelming number of patients who visit this teaching hospital’s doctors want to be told what to do and how to feel. I am the exact opposite; I take personal responsibility for and manage my own health, which is strongly advocated under health care reform. Having a more equal, collaborative relationship with my PCP works for me, and that seems to be the true reason for the administrator’s interference. Studies show that medical malpractice rates drop with a non-paternalistic model of health care services. That fact of reducing litigation risks is pushing more health care systems across the country to migrate to a non-paternalistic model.

    LEGAL ANALYSIS

    I. Formation of Doctor-Patient Relationship

    The first question to address is whether, based on this fact pattern, a doctor-patient relationship was formed. When I gave the Internal Medicine resident doctor confidential information on two off-label drugs that I take, that act would be analogous to a prospective client approaching a lawyer with facts about his case to see if the lawyer will assist him. Contacting a lawyer this way does not create an attorney-client relationship. However, the lawyer is under an ethical duty to protect the confidentiality of the information shared by the prospective client. Similarly, the resident doctor was under an ethical duty to keep the information I shared with him confidential.

    When a lawyer responds to a prospective client, “I agree to take your case,” or “I will be your lawyer,” or words to that effect, then an attorney-client relationship is created, and the protection afforded to the client’s information rises to the level of constitutionally protected attorney-client privilege. In this case, when the resident doctor responded that he would be honored to be my PCP, we have offer and acceptance forming a contract. The offer-acceptance could be construed as my offering to be his patient, which he accepted, or his offer to be my PCP, which I accepted.

    But offer and acceptance are only two of the three required elements to form a contract. The third essential element is exchange of consideration, expressed in Latin as the quid pro quo. In this case, there were several separate exchanges of consideration that complete the formation of a contract and thereby render it enforceable in a court of law. Consideration is defined as some act or some transfer of an item from one party to the other, for which the receiving party had no legal right to otherwise obtain that consideration. There is no requirement that the consideration have intrisinc value. For example, the transfer of a scrap piece of paper can constitute valid consideration that renders a contract binding and enforceable.

    The initial disclosure of confidential information from my health history amounts to sufficient consideration. Second, the fact that both I and the doctor each began pursuing scheduling an appointment for me to see him is also consideration: neither of us had a prior legal right entitling us to that action by the other person. Third, when we continued to correspond after offer and acceptance, with additional information being shared back and forth, further consideration was exchanged. My sending the resident doctor a copy of one of my professional presentations was a fourth example of consideration. Finally, my request that my medical records be transferred to the resident doctor’s clinic constituted an obvious legal detriment based on reliance rendering the contract enforceable.

    If a lawsuit were filed for enforcement of this contract, I am confident that the plaintiff would overcome any attempt to dismiss the lawsuit by the teaching hospital’s attorneys based on the absence of a contract. Defendant might attempt to argue that no contract could be formed, because the resident doctor is not licensed. According to the website http://medical-dictionary.thefreedictionary.com/resident+physician, a “resident physician is a graduate and licensed physician receiving training in a specialty, usually in a hospital.” The resident’s licensing status would not prevent the formation of an enforceable contract, as we have in this fact pattern, for treatment in the supervised residents’ clinic.

    In court, we would pose a series of questions: 1) Is the resident a graduate of a medical school? Yes! 2) Was our conversation focused on health care treatment? Yes! 3) Does the resident see other patients (whether supervised or unsupervised) in the resident clinic? Yes! 4) Are the resident’s services billed to the U.S. government and to private insurers as the services of a doctor (not a student or a doctor’s aide)? Yes! 5) Did we both use the term PCP in describing our relationship? Yes. 6) Did the resident undertake to assist me in obtaining a medical appointment to see him? Yes! With these answers, any court of law is going to recognize if it looks like a duck, swims like a duck, and quacks like a duck, then it is a duck. Therefore, the defendant’s argument on licensing will be viewed as a red herring and will fail. In a similar vein, courts have noted “it is axiomatic that a doctor-patient relationship may arise from, briefly exist, and be limited by the unique circumstances presented in a transfer situation.” Sterling v. Johns Hopkins Hosp., 145 Md. App. 161 (Md. Ct. Spec. App. 2002). It does not matter how long the doctor has been seeing patients or how brief the contact with any given patient, a doctor-patient relationship can be formed.

    Selection of a PCP and other medical decisions are “core” private decisions. A fundamental tenet of privacy jurisprudence, as it has been applied to other types of personal matters, is that the individual most directly concerned is entitled to make and implement the protected decision autonomously and free from paternalistic government intrusion. See, e.g., Zablocki v. Redhail, 434 U.S. 374, 54 L. Ed. 2d 618, 98 S. Ct. 673 (1978) (decision to marry); Moore v. East Cleveland, 431 U.S. 494, 52 L. Ed. 2d 531, 97 S. Ct. 1932 (1977) (decision to live with extended family members); Griswold v. Connecticut, 381 U.S. 479, 14 L. Ed. 2d 510, 85 S. Ct. 1678 (1965)(reproductive choice). I would argue that the constitutional right to privacy also protects autonomy in selecting a PCP among a wide choice of available doctors, selecting which medications I want prescribed, and choosing what lab tests I want to order myself to monitor my health.

    In 2005, the Supreme Court of Arkansas provided the best statement in American jurisprudence on the elevated status of the doctor-patient relationship. The court noted the relationship of doctor-patient is unique. “The loss of this relationship, even temporarily, causes irreparable damage to the doctor and the patient. There is no adequate remedy at law because the loss is a loss of a one-time opportunity.” Baptist Health v. Murphy, 362 Ark. 506 (Ark. 2005)

    The court noted that the hospital had violated the Arkansas Department of Health rules and regulations for hospitals by failing to enforce policies that protected the doctor’s selection of patients and the patient’s choice of a physician. “We interpret this to mean that an otherwise qualified doctor must be granted access to his patient for the purpose of treating his patient, if that is what both the doctor and the patient want. Or, stated another way, a hospital cannot deny the services of a physician of the patient’s choice if the patient is already being seen by physicians at the hospital. Baptist Health v. Murphy, 362 Ark. 510-511 (Ark. 2005)

    Based on reading Baptist Health, I will now forward a copy of this article to the state Department of Health to determine whether the teaching hospital violated any of my state’s regulations requiring Tennessee-licensed medical centers to have policies or bylaws that respect the patient’s right to select his own physician. If so, then the teaching hospital is violating those regulations.

    II. Tennessee’s Tortious Interference Statute

    Tenn. Code Ann. § 47-50-109 is captioned, “Procurement of breach of contracts unlawful – Damages.” The administrator tortiously interfered in my doctor-patient relationship and prevented the resident doctor from performing his services under our contract. She therefore procured a breach of that contract. The administrator will argue that she was merely performing her duties, but that is no excuse for interfering in an existing doctor-patient relationship.

    Although Tennessee jurisprudence does not have a case on point, courts across the country have taken a dim view and expressed disapproval of employer interference in the doctor-patient relationship. For example, the U.S. Supreme Court stated, “The ethical objection has been that intervention by employer… makes a tripartite matter of the doctor-patient relation. Since the contract doctor owes his employment and looks for his pay to the employer… rather than to the patient, he serves two masters with conflicting interests.” United States v. Oregon State Medical Soc., 343 U.S. 326, 329 (U.S. 1952).

    [ad_2]

    Source by Michael Guth

    Views: 0